Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden
· Delayed Price · Currency is SEK 0.2376
-0.0128 (-5.11%)
May 23, 2025, 5:29 PM CET
Xbrane Biopharma AB Revenue
Xbrane Biopharma AB had revenue of 93.24M SEK in the quarter ending March 31, 2025, with 562.90% growth. This brings the company's revenue in the last twelve months to 277.89M, up 45.52% year-over-year. In the year 2024, Xbrane Biopharma AB had annual revenue of 198.72M, down -16.76%.
Revenue (ttm)
277.89M
Revenue Growth
+45.52%
P/S Ratio
1.31
Revenue / Employee
4.34M
Employees
65
Market Cap
364.05M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Medicover AB | 23.56B |
| Camurus AB | 2.04B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |